North America Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report By Component (Software, Hardware, and Services), By Diagnosis, By Country and Growth Forecast, 2024 - 2031

The North America Artificial Intelligence in Diagnostics Market would witness market growth of 20.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Artificial Intelligence in Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,902.4 million by 2031. The Canada market is experiencing a CAGR of 23.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 22.2% during (2024 - 2031).

AI-based dermatology applications use deep learning algorithms to analyze skin images to detect skin diseases, including melanoma, eczema, and psoriasis. Mobile apps powered by AI allow users to perform preliminary skin assessments, improving early diagnosis and treatment accessibility. AI enhances eye disease diagnosis by analyzing retinal scans to detect conditions such as diabetic retinopathy, glaucoma, and macular degeneration. AI-driven eye screening tools provide quick and accurate results, improving early detection and intervention.

Additionally, multiple factors are driving the adoption of AI in diagnostics. The rapid development of deep learning, computer vision, and natural language processing (NLP) has significantly improved the accuracy and efficiency of AI-driven diagnostic tools. AI automates image analysis and decision-making processes by addressing the global shortage of skilled radiologists, pathologists, and other diagnostic specialists.

In Canada, the government’s $196.1 billion investment over ten years, including $46.2 billion in new funding for provinces and territories, will significantly enhance healthcare infrastructure, digital health initiatives, and AI-driven diagnostics. This investment will promote early disease detection, predictive analytics, and AI-powered imaging solutions, improving patient outcomes and reducing diagnostic delays. Additionally, the $2.5 billion allocation for Indigenous healthcare will expand AI-based telemedicine and remote diagnostics, ensuring equitable access to advanced healthcare technologies across underserved communities.

Based on Component, the market is segmented into Software, Hardware, and Services. Based on Diagnosis, the market is segmented into Neurology, Radiology, Chest & Lung, Oncology, Cardiology, Pathology, and Other Diagnosis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Siemens Healthineers AG (Siemens AG)
• Zebra Technologies Corporation
• GE HealthCare Technologies, Inc.
• F. Hoffmann-La Roche Ltd.
• Microsoft Corporation
• NVIDIA Corporation
• IBM Corporation
• DeepScribe Inc.
• AliveCor, Inc.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)

North America Artificial Intelligence in Diagnostics Market Report Segmentation

By Component

• Software
• Hardware
• Services

By Diagnosis

• Neurology
• Radiology
• Chest & Lung
• Oncology
• Cardiology
• Pathology
• Other Diagnosis

By Country

• US
• Canada
• Mexico
• Rest of North America